Delaying the effects of aging through safe hormonal therapy

July 7, 2017
Credit: pixabay

A group of Spanish researchers has developed the basis of a new model to better classify patients when it comes to prescribing anabolic hormone supplementation.

A researcher from Faculty of Sciences for Physical Activity and Sport (INEF) at UPM engaged in a research project that shows the role of muscular function in the correlation between the hormonal status and hospitalization and . As a result of the Toledo Study for Healthy Aging, researchers have designed a clinical method to classify patients that can receive hormonal therapy safely to mitigate the negative effects of aging.

Aging is an inevitable process that entails a series of changes that alter health in a negative way. These changes occur in organs and systems and also at a hormonal level. As the body ages, the concentrations of anabolic hormones tend to decrease.

These hormones transmit messages to the whole organism with the aim of developing new biomolecules—that is, they are associated with the growth of diverse tissues and organs, including the skeletal muscle.

Therefore, this decrease of hormone concentration might cause progressive muscular atrophy due to insufficient regeneration of muscular tissues. In addition, as we grow older, we tend to accumulate more fat mass, and as a result, we have people with physical dysfunction, reduced mobility and, consequently, with greater dependence and mortality.

For this reason, hormone supplementation could be a suitable way of curbing of aging. However, this type of supplementation could have serious adverse effects, such as higher prevalence of cardiovascular events. Starting from this background, the researchers have designed a clinical method to distinguish the patients who could benefit from from the patients who are unsuitable.

"This model not only takes into account the concentration of anabolic hormones in the organism, but also the correlation between these concentrations and the muscular effort exerted by the individual," says Amelia Guadalupe-Grau, a professor at the Faculty of Sciences for Physical Activity and Sport (INEF).

As a result, the muscular function can help better understand the correlations between the levels of anabolic hormones and health events. Thus, researchers will be able to specifically select those patients that should potentially receive hormone therapy and those patients who could benefit most from a physical exercise program.

Researchers observed that mortality risk and hospitalization are closely related to the balance of hormone/total strength ratio. If this ratio is unbalanced, mainly due to a high hormonal concentration for average values or low muscular strength or when strength levels are below the hormonal levels, hormonal deregulation occurs.

It is believed that at least part of this deregulation is due to the fact that the receptors of these hormones do not work properly, and therefore the muscular atrophy is not caused by the lack of anabolic hormones, but because target organs of these hormones cannot grasp them properly, and the signal does not arrive.

"We have to be careful when supplementing with hormones. We need to ensure that we are using the right dose. When the dose is small, it causes no effect. However, if the dose exceeds the right values, the adverse effects such as cardiovascular events are much common," says Dr. Guadalupe-Grau. This new method will allow physicians to prescribe the hormone treatment in a safer way for the patient.

According to this study, which was published in Journal of the American Medical Directors Association (JAMDA), hormone supplementation is inappropriate when have a hormonal deregulation caused by a failure in the receptors (indirectly measured through the muscular strength).

Explore further: Higher anabolic hormone levels predict lower risk of worsening frailty in men

More information: Amelia Guadalupe-Grau et al. Endocrinology of Aging From a Muscle Function Point of View: Results From the Toledo Study for Healthy Aging, Journal of the American Medical Directors Association (2016). DOI: 10.1016/j.jamda.2016.09.005

Related Stories

Higher anabolic hormone levels predict lower risk of worsening frailty in men

April 3, 2017
A new study suggests that middle-age and elderly men are less likely to develop worsening frailty if they have high levels of certain anabolic hormones, which are muscle- and bone-building hormones. The study results will ...

Research debunks bodybuilding myth: Growth-promoting hormones don't stimulate strength

June 14, 2012
New research from scientists at McMaster University reveals exercise-related testosterone and growth hormone do not play an influential role in building muscle after weightlifting, despite conventional wisdom suggesting otherwise.

Cardiac risk a factor when considering hormonal therapy for prostate cancer

September 28, 2016
In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack. The findings were presented September 28 at ...

Low thyroid levels may signal heightened risk of death in hospitalized patients

October 30, 2013
Older individuals hospitalized with a serious condition may face a slimmer risk of surviving if their thyroid hormone levels are low, according to a recent study accepted for publication in The Endocrine Society's Journal ...

One-third of hormone users at menopause take unapproved, untested compounded drugs

September 30, 2015
A third of US women who take hormones at menopause are using compounded hormones, shows a new national survey. These women commonly—and mistakenly—think these hormones are safer and offer more benefits than FDA-approved ...

Postmenopausal hormone therapy exceeding ten years may protect from dementia

February 16, 2017
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.

Recommended for you

Exercise can make cells healthier, promoting longer life, study finds

September 22, 2017
Whether it's running, walking, cycling, swimming or rowing, it's been well-known since ancient times that doing some form of aerobic exercise is essential to good health and well-being. You can lose weight, sleep better, ...

Breathing dirty air may harm kidneys, study finds

September 21, 2017
Outdoor air pollution has long been linked to major health conditions such as heart disease, stroke, cancer, asthma and chronic obstructive pulmonary disease. A new study now adds kidney disease to the list, according to ...

Excess dietary manganese promotes staph heart infection

September 21, 2017
Too much dietary manganese—an essential trace mineral found in leafy green vegetables, fruits and nuts—promotes infection of the heart by the bacterium Staphylococcus aureus ("staph").

Being active saves lives whether a gym workout, walking to work or washing the floor

September 21, 2017
Physical activity of any kind can prevent heart disease and death, says a large international study involving more than 130,000 people from 17 countries published this week in The Lancet.

Frequent blood donations safe for some, but not all

September 21, 2017
(HealthDay)—Some people may safely donate blood as often as every eight weeks—but that may not be a healthy choice for all, a new study suggests.

Higher manganese levels in children correlate with lower IQ scores, study finds

September 21, 2017
A study led by environmental health researchers at the University of Cincinnati (UC) College of Medicine finds that children in East Liverpool, Ohio with higher levels of Manganese (Mn) had lower IQ scores. The research appears ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.